US 12030935
Anti-PDGF-B antibodies and pharmaceutical composition thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 12030935 (Anti-PDGF-B antibodies and pharmaceutical composition thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61P, A61P11/00, A61P43/00